Steven Pfanstiel
Director of Finance/CFO bei MARINUS PHARMACEUTICALS, INC.
Vermögen: 114 989 $ am 31.03.2024
Profil
Steven E.
Pfanstiel is currently the Chief Financial & Operating Officer, Treasurer at Marinus Pharmaceuticals, Inc. He previously worked as the Senior Director-Research & Development at Animas LLC from 2013 to 2016, the Senior Director-Financial Planning & Analysis at OptiNose, Inc. from 2018 to 2020, the Senior Director-Global Strategic Marketing at DePuy Synthes, Inc. from 2016 to 2018, and the Vice President-Finance at Lifescan, Inc. from 2020 to 2021.
Mr. Pfanstiel holds a graduate degree from Clemson University, an undergraduate degree from Wabash College, and an MBA from Kelley School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.04.2024 | 12 720 ( 0,02% ) | 114 989 $ | 31.03.2024 |
Aktive Positionen von Steven Pfanstiel
Unternehmen | Position | Beginn |
---|---|---|
MARINUS PHARMACEUTICALS, INC. | Director of Finance/CFO | 12.04.2021 |
Ehemalige bekannte Positionen von Steven Pfanstiel
Unternehmen | Position | Ende |
---|---|---|
Lifescan, Inc.
Lifescan, Inc. Medical/Nursing ServicesHealth Services Lifescan, Inc. engages in the development, manufacture, and market of blood glucose monitoring products. Its portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The company was founded by Gary H. Stroy in 1981 and is headquartered in Wayne, PA. | Director of Finance/CFO | 01.03.2021 |
OPTINOSE, INC. | Corporate Officer/Principal | 01.01.2020 |
DePuy Synthes, Inc.
DePuy Synthes, Inc. Medical SpecialtiesHealth Technology The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN. | Corporate Officer/Principal | 01.02.2018 |
Animas LLC
Animas LLC Medical SpecialtiesHealth Technology Animas LLC manufactures and distributes external insulin pumps for diabetes patients. The company was founded on November 5, 1996 and is headquartered in West Chester, PA. | Chief Tech/Sci/R&D Officer | 01.07.2016 |
Ausbildung von Steven Pfanstiel
Clemson University | Graduate Degree |
Wabash College | Undergraduate Degree |
Kelley School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MARINUS PHARMACEUTICALS, INC. | Health Technology |
OPTINOSE, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Animas LLC
Animas LLC Medical SpecialtiesHealth Technology Animas LLC manufactures and distributes external insulin pumps for diabetes patients. The company was founded on November 5, 1996 and is headquartered in West Chester, PA. | Health Technology |
Lifescan, Inc.
Lifescan, Inc. Medical/Nursing ServicesHealth Services Lifescan, Inc. engages in the development, manufacture, and market of blood glucose monitoring products. Its portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The company was founded by Gary H. Stroy in 1981 and is headquartered in Wayne, PA. | Health Services |
DePuy Synthes, Inc.
DePuy Synthes, Inc. Medical SpecialtiesHealth Technology The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN. | Health Technology |